Dementia is common, but there are things you can do to reduce your risk or slow the progression of the disease.

Research shows the p-tau217 blood test can indicate very high risk of Alzheimer's disease before symptoms begin, offering ...

But in people with dementia —which is an umbrella term for mental decline and can be related to a number of diseases such as ...

New research suggests that unusual changes in eating behavior—rather than memory loss—may be one of the earliest signs of a ...

There is no single, easy test to diagnose Alzheimer’s, but a new review of 18 scientific studies confirms that a simple blood ...

The outlook for dementia care is changing fast. UC experts explain what that means for patients and families, and what it ...

Early Alzheimer's patients who completed their course of donanemab therapy by 12 months had cognitive and functional benefits lasting for 2 additional years, reported Jennifer Zimmer, MD, of Eli Lilly ...

Having dementia can seem like the end of everything. But in some ways, it’s only the beginning. “The most important thing ...

Despite encouraging biomarker shifts, oral semaglutide failed to slow cognitive decline in early Alzheimer’s, leading to an ...

GLP-1 drugs, which include Ozempic and Wegovy, have become one of the most closely watched experimental approaches for ...

Details from two large trials of Novo Nordisk's GLP-1 drug semaglutide showed it provided no cognitive benefit for people ...